实用妇科内分泌电子杂志
實用婦科內分泌電子雜誌
실용부과내분비전자잡지
Journal of Practical Gynecologic Endocrinology
2014年
2期
21-22
,共2页
瘢痕子宫%子宫瘢痕妊娠%米非司酮%双侧子宫动脉化疗栓塞术
瘢痕子宮%子宮瘢痕妊娠%米非司酮%雙側子宮動脈化療栓塞術
반흔자궁%자궁반흔임신%미비사동%쌍측자궁동맥화료전새술
Scar Uterus%Uterine Scar Pregnancy%Mifepristone%Bilateral UterineArterial ChemoemBolization
目的：研究分析口服米非司酮、宫腔镜手术以及双侧子宫动脉化疗栓塞术在治疗子宫瘢痕妊娠的疗效。方法本研究选取2010年5月～2014年5月因前次剖宫产后再次子宫瘢痕妊娠的患者45例，按随机分组的方法，将入选病例平均分为三组，分别为：米非司酮组、宫腔镜组和子宫动脉栓塞组。米非司酮组给予口服米非司酮治疗。宫腔镜组给予宫腔镜下瘢痕妊娠灶清除术。子宫动脉栓塞组给予经子宫动脉化疗栓塞治疗。观察患者经过治疗后血β-HCG数值变化情况和复查妇科彩超结果，评价疗效。数据结果均经过统计学软件处理分析数据。结果米非司酮组血β-HCG下降至正常的时间平均（25.34±6.21）d，治疗后1月复查妇科彩超，治愈率达81.5%。宫腔镜组血β-HCG下降至正常的时间平均（7.13±2.46）d，治疗后1月复查妇科彩超，治愈率达100%。子宫动脉栓塞组血β-HCG下降至正常的时间平均（13.57±4.31）d，治疗后1月复查妇科彩超，治愈率达95%。结论子宫瘢痕妊娠的治疗方法中，宫腔镜下妊娠灶清除术最为有效，其次是双侧子宫动脉化疗栓塞术，最后是口服米非司酮治疗。
目的：研究分析口服米非司酮、宮腔鏡手術以及雙側子宮動脈化療栓塞術在治療子宮瘢痕妊娠的療效。方法本研究選取2010年5月～2014年5月因前次剖宮產後再次子宮瘢痕妊娠的患者45例，按隨機分組的方法，將入選病例平均分為三組，分彆為：米非司酮組、宮腔鏡組和子宮動脈栓塞組。米非司酮組給予口服米非司酮治療。宮腔鏡組給予宮腔鏡下瘢痕妊娠竈清除術。子宮動脈栓塞組給予經子宮動脈化療栓塞治療。觀察患者經過治療後血β-HCG數值變化情況和複查婦科綵超結果，評價療效。數據結果均經過統計學軟件處理分析數據。結果米非司酮組血β-HCG下降至正常的時間平均（25.34±6.21）d，治療後1月複查婦科綵超，治愈率達81.5%。宮腔鏡組血β-HCG下降至正常的時間平均（7.13±2.46）d，治療後1月複查婦科綵超，治愈率達100%。子宮動脈栓塞組血β-HCG下降至正常的時間平均（13.57±4.31）d，治療後1月複查婦科綵超，治愈率達95%。結論子宮瘢痕妊娠的治療方法中，宮腔鏡下妊娠竈清除術最為有效，其次是雙側子宮動脈化療栓塞術，最後是口服米非司酮治療。
목적：연구분석구복미비사동、궁강경수술이급쌍측자궁동맥화료전새술재치료자궁반흔임신적료효。방법본연구선취2010년5월～2014년5월인전차부궁산후재차자궁반흔임신적환자45례，안수궤분조적방법，장입선병례평균분위삼조，분별위：미비사동조、궁강경조화자궁동맥전새조。미비사동조급여구복미비사동치료。궁강경조급여궁강경하반흔임신조청제술。자궁동맥전새조급여경자궁동맥화료전새치료。관찰환자경과치료후혈β-HCG수치변화정황화복사부과채초결과，평개료효。수거결과균경과통계학연건처리분석수거。결과미비사동조혈β-HCG하강지정상적시간평균（25.34±6.21）d，치료후1월복사부과채초，치유솔체81.5%。궁강경조혈β-HCG하강지정상적시간평균（7.13±2.46）d，치료후1월복사부과채초，치유솔체100%。자궁동맥전새조혈β-HCG하강지정상적시간평균（13.57±4.31）d，치료후1월복사부과채초，치유솔체95%。결론자궁반흔임신적치료방법중，궁강경하임신조청제술최위유효，기차시쌍측자궁동맥화료전새술，최후시구복미비사동치료。
Objective To study the analysis of oral mifepristone, hysteroscopy surgery and bilateral uterine arterial chemoembolization in the treatment of uterine scar pregnancy curative effect. Methods This study selected in May 2010 to May 2014 because of previous cesarean section 45 cases of patients with uterine scar pregnancy again, according to randomized method, average selected cases can be divided into three groups, respectively: mifepristone group, hysteroscopy group and uterine artery embolization. Oral mifepristone treatment group was given mifepristone. Hysteroscopy group was given for removal of scar pregnancy focal under hysteroscopy. Uterine artery embolization group was given after uterine artery embolization chemotherapy. Observed after treatment in patients with blood beta HCG, the change of the value and the review of department of gynaecology exceeds a result, the evaluation of therapeutic effect. The data were analyzed by statistical software data. Results Blood beta HCG mifepristone group dropped to normal time average (25.34 ± 6.21) days, 1 month after treatment of department of gynaecology exceeds, review of the cure rate was 81.5%. Hysteroscopy group blood beta HCG dropped to normal time average (7.13 ± 2.46) days, 1 month after treatment of department of gynaecology exceeds, review of the cure rate was 100%. Uterine artery embolization group blood beta HCG dropped to normal time average (13.57 ± 4.31) days, 1 month after treatment of department of gynaecology exceeds, review of the cure rate was 95%. Conclusion The treatment of uterine scar pregnancy, pregnancy under hysteroscopy focal elimination is the most effective, followed by bilateral uterine artery chemoembolization, finally is oral mifepristone treatment.
